Human medicines European public assessment report (EPAR): Increlex, mecasermin, Date of authorisation: 02/08/2007, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Lyrica, pregabalin, Date of authorisation: 05/07/2004, Revision: 71, Status: Authorised

ACT EU workshop on ICH E6 R3 (principles and Annex 1) , Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 19 February 2025, 09:30 (CET) to 20 February 2025, 14:00 (CET)

Management Board meeting dates 2026-2027

Q&A clinic on Substance, Organisation, Referentials Management Services, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 8 September 2025, 11:00 (CEST) to 8 September 2025, 12:00 (CEST)

Cancer Medicines Forum: June 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 17 June 2025, 14:00 (CEST) to 17 June 2025, 17:00 (CEST)

Human medicines European public assessment report (EPAR): Leqvio, inclisiran, Date of authorisation: 09/12/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Replagal, agalsidase alfa, Date of authorisation: 03/08/2001, Revision: 29, Status: Authorised

Network Data Steering Group (NDSG)

Overview of Network Data Steering Group (NDSG) change management activities 2025-2026